NRx Pharmaceuticals receives FDA clearance for depression trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. PRIM
4. MU
5. DPZ
6. NAVN
7. DFTX
8. META
9. IMNN
10. ACN

Go back to NRx Pharmaceuticals receives FDA clearance for depression trial
(NASDAQ: NRXP) Delayed: 3.90 --0 (-0%)
Previous Close $3.90    52 Week High $ 
Open $3.90    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.90    EPS $ 
Volume 30,758